Fingolimod after natalizumab and the risk of short-term relapse

OBJECTIVE: To determine early risk of relapse after switch from natalizumab to fingolimod; to compare the switch experience to that in patients switching from interferon-β/glatiramer acetate (IFN-β/GA) and those previously treatment naive; and to determine predictors of time to first relapse on fing...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Jokubaitis, Vilija G., Li, Vivien, Kalincik, Tomas, Izquierdo, Guillermo, Hodgkinson, Suzanne, Alroughani, Raed, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Duquette, Pierre, Girard, Marc, Barnett, Michael, Grand'Maison, Francois, Trojano, Maria, Slee, Mark, Giuliani, Giorgio, Shaw, Cameron, Boz, Cavit, Spitaleri, Daniele L.A., Verheul, Freek, Haartsen, Jodi, Liew, Danny, Butzkueven, Helmut
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4001200/
https://ncbi.nlm.nih.gov/pubmed/24610329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000283
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items